Although the etiology of IBD remains unclear, active IBD patients typically exhibit reduced serum IGF-1 levels (54), which may be secondary to gastrointestinal dysfunction and acquired growth hormone resistance (55). This evidence concerns the gene IGF1 and inflammatory bowel disease.